BRCA1 and breast carcinoma: Of the 40 women, 18 (45%) had no known mutation in breast cancer genes, 20 of 40 (50%) had a pathologic variant of BRCA1/2, and 2 of 40 (5.0%) had a pathologic variant of other breast cancer genes.